Finizio Robert G
Insider CIK 1532235 · ZVSA Director · TXMD Chairman/CEO, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ZVSA ZyVersa Therapeutics, Inc. | A Award deriv | 2025-07-11 | 2025-07-15 | 11,066 | — | $0 | 11,066 | SEC↗ |
| ZVSA ZyVersa Therapeutics, Inc. | A Award deriv | 2023-05-24 | 2024-07-18 | 132 | — | $0 | 132 | SEC↗ |
| ZVSA ZyVersa Therapeutics, Inc. | A Award deriv | 2022-12-12 | 2022-12-14 | 29,781 | — | $0 | 29,781 | SEC↗ |
| ZVSA ZyVersa Therapeutics, Inc. | A Award deriv | 2022-12-12 | 2022-12-14 | 9,927 | — | $0 | 9,927 | SEC↗ |
| ZVSA ZyVersa Therapeutics, Inc. | A Award deriv | 2022-12-12 | 2022-12-14 | 19,854 | — | $0 | 19,854 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2021-07-01 | 2021-07-02 | 1,493,333 | — | $0 | 1,493,333 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2021-07-01 | 2021-07-02 | 746,667 | — | $0 | 746,667 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | S Sale | 2021-05-11 | 2021-05-12 | 67,697 | $1.04 | $70.4K | 17,991,637 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise deriv | 2021-05-10 | 2021-05-12 | 158,334 | — | $0 | 316,666 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise | 2021-05-10 | 2021-05-12 | 158,334 | — | $0 | 18,059,334 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | G Gift | 2021-03-05 | 2021-03-08 | 350,000 | — | $0 | 18,201,000 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | X Exercise deriv | 2021-03-04 | 2021-03-08 | 179,000 | — | $0 | 0 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | X Exercise | 2021-03-04 | 2021-03-08 | 179,000 | $0.24 | $43.0K | 18,580,964 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | F Tax w/h | 2021-03-04 | 2021-03-08 | 29,964 | $1.46 | $43.7K | 18,551,000 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2020-11-24 | 2020-11-27 | 1 | — | $0 | 1 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | P Buy | 2020-06-09 | 2020-06-10 | 21,000 | $1.41 | $29.6K | 18,376,964 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | P Buy | 2020-06-09 | 2020-06-10 | 25,000 | $1.47 | $36.8K | 18,401,964 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | P Buy | 2020-06-05 | 2020-06-08 | 10,000 | $1.16 | $11.6K | 18,335,964 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | P Buy | 2020-06-05 | 2020-06-08 | 20,000 | $1.15 | $23.0K | 18,355,964 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2020-03-30 | 2020-04-01 | 475,000 | — | $0 | 475,000 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2020-03-30 | 2020-04-01 | 475,000 | — | $0 | 475,000 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | G Gift | 2020-02-28 | 2021-03-08 | 300,000 | — | $0 | 17,901,000 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | P Buy | 2019-10-25 | 2019-10-29 | 72,000 | $2.75 | $198.0K | 18,325,964 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2019-08-28 | 2019-08-30 | 1 | — | $0 | 1 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | P Buy | 2019-08-20 | 2019-08-20 | 35,000 | $2.74 | $95.9K | 18,253,964 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | P Buy | 2019-08-09 | 2019-08-12 | 52,405 | $2.96 | $155.1K | 18,218,964 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | G Gift | 2019-02-28 | 2019-08-12 | 200,000 | — | $0 | 18,166,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise deriv | 2018-12-20 | 2018-12-21 | 92,910 | — | $0 | 0 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | S Sale | 2018-12-20 | 2018-12-21 | 92,910 | $3.63 | $337.3K | 18,366,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise | 2018-12-20 | 2018-12-21 | 92,910 | $0.10 | $9.3K | 18,459,469 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise deriv | 2018-12-19 | 2018-12-21 | 92,000 | — | $0 | 92,910 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise | 2018-12-19 | 2018-12-21 | 92,000 | $0.10 | $9.2K | 18,458,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | S Sale | 2018-12-19 | 2018-12-21 | 92,000 | $3.70 | $340.4K | 18,366,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise deriv | 2018-12-07 | 2018-12-10 | 92,000 | — | $0 | 184,910 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | S Sale | 2018-12-07 | 2018-12-10 | 92,000 | $4.60 | $423.2K | 18,366,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise | 2018-12-07 | 2018-12-10 | 92,000 | $0.10 | $9.2K | 18,458,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise deriv | 2018-12-06 | 2018-12-10 | 92,000 | — | $0 | 276,910 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise | 2018-12-06 | 2018-12-10 | 92,000 | $0.10 | $9.2K | 18,458,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | G Gift | 2018-12-06 | 2018-12-10 | 27,000 | — | $0 | 18,366,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | S Sale | 2018-12-06 | 2018-12-10 | 92,000 | $4.57 | $420.4K | 18,366,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise deriv | 2018-11-27 | 2018-11-28 | 92,000 | — | $0 | 368,910 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | S Sale | 2018-11-27 | 2018-11-28 | 92,000 | $4.81 | $442.5K | 18,393,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise | 2018-11-27 | 2018-11-28 | 92,000 | $0.10 | $9.2K | 18,485,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise deriv | 2018-11-26 | 2018-11-28 | 92,000 | — | $0 | 460,910 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | S Sale | 2018-11-26 | 2018-11-28 | 92,000 | $4.86 | $447.1K | 18,393,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise | 2018-11-26 | 2018-11-28 | 92,000 | $0.10 | $9.2K | 18,485,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise deriv | 2018-11-13 | 2018-11-14 | 92,000 | — | $0 | 552,910 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | S Sale | 2018-11-13 | 2018-11-14 | 92,000 | $4.81 | $442.5K | 18,393,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise | 2018-11-13 | 2018-11-14 | 92,000 | $0.10 | $9.2K | 18,485,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise deriv | 2018-11-12 | 2018-11-14 | 92,000 | — | $0 | 644,910 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise | 2018-11-12 | 2018-11-14 | 92,000 | $0.10 | $9.2K | 18,485,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | S Sale | 2018-11-12 | 2018-11-14 | 92,000 | $4.73 | $435.2K | 18,393,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise deriv | 2018-10-26 | 2018-10-29 | 92,000 | — | $0 | 736,910 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise | 2018-10-26 | 2018-10-29 | 92,000 | $0.10 | $9.2K | 18,485,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | S Sale | 2018-10-26 | 2018-10-29 | 92,000 | $5.12 | $471.0K | 18,393,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise deriv | 2018-10-25 | 2018-10-29 | 92,000 | — | $0 | 828,910 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | S Sale | 2018-10-25 | 2018-10-29 | 92,000 | $5.45 | $501.4K | 18,393,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise | 2018-10-25 | 2018-10-29 | 92,000 | $0.10 | $9.2K | 18,485,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise deriv | 2018-10-12 | 2018-10-15 | 92,000 | — | $0 | 920,910 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | S Sale | 2018-10-12 | 2018-10-15 | 92,000 | $5.45 | $501.4K | 18,393,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise | 2018-10-12 | 2018-10-15 | 92,000 | $0.10 | $9.2K | 18,485,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise deriv | 2018-10-11 | 2018-10-15 | 92,000 | — | $0 | 1,012,910 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | S Sale | 2018-10-11 | 2018-10-15 | 92,000 | $5.65 | $519.8K | 18,393,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise | 2018-10-11 | 2018-10-15 | 92,000 | $0.10 | $9.2K | 18,485,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise deriv | 2018-09-21 | 2018-09-24 | 92,000 | — | $0 | 1,104,910 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise | 2018-09-21 | 2018-09-24 | 92,000 | $0.10 | $9.2K | 18,485,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | S Sale | 2018-09-21 | 2018-09-24 | 92,000 | $6.67 | $613.6K | 18,393,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise deriv | 2018-09-20 | 2018-09-24 | 92,000 | — | $0 | 1,196,910 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | S Sale | 2018-09-20 | 2018-09-24 | 92,000 | $6.58 | $605.4K | 18,393,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise | 2018-09-20 | 2018-09-24 | 92,000 | $0.10 | $9.2K | 18,485,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise deriv | 2018-09-07 | 2018-09-10 | 92,000 | — | $0 | 1,288,910 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | S Sale | 2018-09-07 | 2018-09-10 | 92,000 | $6.22 | $572.2K | 18,393,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise | 2018-09-07 | 2018-09-10 | 92,000 | $0.10 | $9.2K | 18,485,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise deriv | 2018-09-06 | 2018-09-10 | 92,000 | — | $0 | 1,380,910 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | S Sale | 2018-09-06 | 2018-09-10 | 92,000 | $6.25 | $575.0K | 18,393,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise | 2018-09-06 | 2018-09-10 | 92,000 | $0.10 | $9.2K | 18,485,559 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2018-03-15 | 2018-03-19 | 440,000 | — | $0 | 440,000 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2017-03-15 | 2017-03-17 | 445,000 | — | $0 | 445,000 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2015-12-17 | 2015-12-21 | 950,000 | — | $0 | 950,000 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise deriv | 2014-05-09 | 2014-05-12 | 31,526 | — | $0 | 268,474 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise | 2014-05-09 | 2014-05-12 | 31,526 | $3.00 | $94.6K | 21,061,059 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | S Sale | 2014-03-26 | 2014-03-28 | 982,053 | $6.70 | $6.58M | 21,029,533 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | S Sale | 2014-02-21 | 2014-02-21 | 16,600 | $6.18 | $102.6K | 22,011,586 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | S Sale | 2014-02-20 | 2014-02-21 | 16,700 | $6.17 | $103.0K | 22,028,186 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | S Sale | 2014-02-19 | 2014-02-21 | 16,700 | $6.17 | $103.0K | 22,044,886 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | S Sale | 2014-01-23 | 2014-01-23 | 16,600 | $5.92 | $98.3K | 22,061,586 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | S Sale | 2014-01-22 | 2014-01-23 | 16,700 | $5.66 | $94.5K | 22,078,186 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | S Sale | 2014-01-21 | 2014-01-23 | 16,700 | $5.53 | $92.4K | 22,094,886 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2012-11-30 | 2012-12-04 | 900,000 | — | $0 | 2,927,481 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2012-04-16 | 2012-12-04 | 50,000 | — | $0 | 2,027,481 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2012-04-16 | 2012-04-17 | 50,000 | — | $0 | 2,027,481 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2012-02-27 | 2012-03-16 | 300,000 | — | $0 | 1,977,481 | SEC↗ |